文献速递淋巴瘤

解析转化性脾边缘区淋巴瘤的遗传学机制

Unraveling the genetics of transformed splenic marginal zone lymphoma.
PubMed 文献 · Blood Adv · 2023-01-01

研究纳入41例最终发生大B细胞淋巴瘤转化的脾边缘区淋巴瘤(SMZL)患者,采用拷贝数芯片和定制二代测序panel分析诊断与转化样本。转化样本基因组复杂性更高,TNFAIP3、TP53改变及9p21.3缺失、6p获得更常见;SMZL与转化克隆多来自共同前体细胞的分歧演化。KLF2突变、复杂核型和转化时国际预后指数评分与转化后较短生存相关。

要点

  • SMZL转化后基因组复杂性升高,TNFAIP3、TP53改变及9p21.3缺失、6p获得更常见。
  • 92%(12/13例)可评估病例中,SMZL与转化克隆由共同前体细胞分歧演化而来。
  • KLF2突变、复杂核型及转化时国际预后指数评分预测转化后较短生存。

核心结论

  • SMZL-T以高于SMZL的基因组复杂性及特征性基因组改变为特点,这些改变可能是转化事件的关键驱动因素。

研究设计与样本

  • 研究纳入41例最终发生大B细胞淋巴瘤转化的SMZL患者,肿瘤材料仅在诊断时获取9例、诊断和转化时获取18例、仅在转化时获取14例。
  • 样本分为诊断组(SMZL,n=27份样本)和转化组(SMZL-T,n=32份样本),采用拷贝数芯片和定制二代测序panel分析。

主要发现

  • SMZL-T的主要基因组改变涉及TNFAIP3、KMT2D、TP53、ARID1A、KLF2、1q获得、9p21.3(CDKN2A/B)缺失和7q31-q32缺失。
  • 与SMZL相比,SMZL-T具有更高的基因组复杂性,以及更高发生率的TNFAIP3和TP53改变、9p21.3(CDKN2A/B)缺失和6p获得。
  • 在几乎所有可评估病例(92%,12/13例)中,SMZL和SMZL-T克隆由共同异常前体细胞分歧演化而来,获得不同遗传学改变。
  • 对1例患者诊断和转化样本的全基因组测序显示,SMZL-T样本比诊断样本携带更多基因组畸变,两样本均存在易位t(14;19)(q32;q13),转化时因染色体碎裂获得局灶性B2M缺失。
  • 生存分析显示,KLF2突变、复杂核型和转化时国际预后指数评分分别预测转化后较短生存(P=0.001;P=0.042;P=0.007)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The genetic mechanisms associated with splenic marginal zone lymphoma (SMZL) transformation are not well defined. We studied 41 patients with SMZL that eventually underwent large B-cell lymphoma transformation. Tumor material was obtained either only at diagnosis (9 patients), at diagnosis and transformation (18 patients), and only at transformation (14 patients). Samples were categorized in 2 groups: (1) at diagnosis (SMZL, n = 27 samples), and (2) at transformation (SMZL-T, n = 32 samples). Using copy number arrays and a next-generation sequencing custom panel, we identified that the main genomic alterations in SMZL-T involved TNFAIP3, KMT2D, TP53, ARID1A, KLF2, 1q gains, and losses of 9p21.3 (CDKN2A/B) and 7q31-q32. Compared with SMZL, SMZL-T had higher genomic complexity, and higher incidence of TNFAIP3 and TP53 alterations, 9p21.3 (CDKN2A/B) losses, and 6p gains. SMZL and SMZL-T clones arose by divergent evolution from a common altered precursor cell that acquired different genetic alterations in virtually all evaluable cases (92%, 12 of 13 cases). Using whole-genome sequencing of diagnostic and transformation samples in 1 patient, we observed that the SMZL-T sample carried more genomic aberrations than the diagnostic sample, identified a translocation t(14;19)(q32;q13) present in both samples, and detected a focal B2M deletion due to chromothripsis acquired at transformation. Survival analysis showed that KLF2 mutations, complex karyotype, and International Prognostic Index score at transformation were predictive of a shorter survival from transformation (P = .001; P = .042; and P = .007; respectively). In summary, SMZL-T are characterized by higher genomic complexity than SMZL, and characteristic genomic alterations that could represent key players in the transformation event.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Grau M, López C, Navarro A, et al. Unraveling the genetics of transformed splenic marginal zone lymphoma. Blood Adv. 2023. PMID: 36995085. doi:10.1182/bloodadvances.2022009415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。